Mankind Pharma Limited (BOM:543904)
India flag India · Delayed Price · Currency is INR
2,423.15
-39.95 (-1.62%)
At close: Mar 28, 2025

Mankind Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019
Market Capitalization
999,224921,654----
Upgrade
Enterprise Value
959,022902,241----
Upgrade
Last Close Price
2421.152297.35----
Upgrade
PE Ratio
48.9548.18----
Upgrade
PS Ratio
10.218.92----
Upgrade
PB Ratio
11.019.63----
Upgrade
P/TBV Ratio
13.3212.00----
Upgrade
P/FCF Ratio
50.17----
Upgrade
P/OCF Ratio
42.82----
Upgrade
EV/Sales Ratio
8.248.73----
Upgrade
EV/EBITDA Ratio
32.9535.57----
Upgrade
EV/EBIT Ratio
38.8341.93----
Upgrade
EV/FCF Ratio
49.11----
Upgrade
Debt / Equity Ratio
0.050.020.020.140.060.04
Upgrade
Debt / EBITDA Ratio
0.170.080.090.440.160.09
Upgrade
Debt / FCF Ratio
-0.110.171.940.340.16
Upgrade
Asset Turnover
-0.950.931.001.091.28
Upgrade
Inventory Turnover
-2.181.841.691.772.24
Upgrade
Quick Ratio
-2.021.140.651.781.33
Upgrade
Current Ratio
-3.102.321.682.892.26
Upgrade
Return on Equity (ROE)
-22.58%18.79%25.99%30.30%31.75%
Upgrade
Return on Assets (ROA)
-12.41%10.53%14.76%17.37%20.01%
Upgrade
Return on Capital (ROIC)
15.29%15.30%13.24%18.56%22.22%26.05%
Upgrade
Return on Capital Employed (ROCE)
-21.90%20.20%28.10%31.70%38.50%
Upgrade
Earnings Yield
2.04%2.08%----
Upgrade
FCF Yield
1.99%----
Upgrade
Payout Ratio
0.00%----29.35%
Upgrade
Buyback Yield / Dilution
-0.20%-0.14%-0.00%---
Upgrade
Total Shareholder Return
-0.20%-0.14%-0.00%---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.